Literature DB >> 17675361

Prolonged residual paralysis after a single intubating dose of rocuronium.

C Claudius1, H Karacan, J Viby-Mogensen.   

Abstract

It is often argued that neuromuscular monitoring is unnecessary when only one dose of an intermediate-acting neuromuscular blocking agent is given. This case report documents that it may take more than 3.5 h before it is possible to antagonize a block caused by a normal dose of rocuronium (0.6 mg kg(-1)). Possible causes of the extremely prolonged duration of action are discussed, as is the importance of quantitative neuromuscular monitoring.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17675361     DOI: 10.1093/bja/aem213

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  6 in total

1.  Is it not the time to stop the use of Scoline (suxamethonium chloride) for rapid sequence intubation?

Authors:  Sangeet Narang
Journal:  Sultan Qaboos Univ Med J       Date:  2011-10-25

2.  Management of Residual Neuromuscular Blockade Recovery: Age-Old Problem with a New Solution.

Authors:  Michael S Green; Archana Gundigi Venkatesh; Ranjani Venkataramani
Journal:  Case Rep Anesthesiol       Date:  2017-03-14

3.  Neuromuscular Blockade Correlates with Hormones and Body Composition in Acromegaly.

Authors:  Yu Zhang; Xiaopeng Guo; Gang Tan; Mengyun Zhao; Yuguang Huang; Wei Chen; Xiaodong Shi; Lijian Pei; Bing Xing
Journal:  Int J Endocrinol       Date:  2020-12-09       Impact factor: 3.257

4.  A surgeon's assessment of inadequate neuromuscular antagonism in a case of prolonged neuromuscular blockade.

Authors:  James J Lamberg; Joseph F Answine
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2013-04

5.  Comparison between the Effects of Rocuronium, Vecuronium, and Cisatracurium Using Train-of-Four and Clinical Tests in Elderly Patients.

Authors:  Ozlem Sagir; Funda Yucesoy Noyan; Ahmet Koroglu; Muslum Cicek; Huseyin Ilksen Toprak
Journal:  Anesth Pain Med       Date:  2013-03-26

6.  Use of sugammadex in patients with neuromuscular disorders: a systematic review of case reports.

Authors:  Usha Gurunathan; Shakeel Meeran Kunju; Lisa May Lin Stanton
Journal:  BMC Anesthesiol       Date:  2019-11-19       Impact factor: 2.217

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.